Caro J, Brown S, Miller O, Murray T, Erslev A J
J Lab Clin Med. 1979 Mar;93(3):449-58.
Erythropoietin titers were measured in anemic nephric and anephric patients undergoing chronic hemodialysis by utilizing a plasma concentration technique. In eight out of 11 anephric patients studied, decreased but detectable levels of erythropoietin were found, suggesting that extrarenal erythropoietin plays a role in the regulation of red cell production in anephric patients. In 14 nephric uremic patients, erythropoietin production was found to be more variable, with one group of eight patients having erythropoietin levels in the range for normal nonanemic individuals (3.9 to 15 mU/ml), and a second group of six patients with erythropoietin higher than normal (greater than 15 mU/ml). Both groups were found to be equally anemic, indicating that in the second group the bone marrow is less responsive to erythropoietin. The severity of secondary hyperparathyroidism was found to be higher in this second group, suggesting a role of PTH in the bone marrow unresponsiveness. A good correlation between biological and immunological erythropoietin activities was found in the plasma from normal subjects and uremic nephric and anephric patients.
利用血浆浓度技术,对接受慢性血液透析的贫血肾病患者和无肾患者的促红细胞生成素滴度进行了测量。在11例接受研究的无肾患者中,有8例发现促红细胞生成素水平降低但仍可检测到,这表明肾外促红细胞生成素在无肾患者红细胞生成的调节中发挥作用。在14例肾病尿毒症患者中,促红细胞生成素的产生更具变异性,一组8例患者的促红细胞生成素水平在正常非贫血个体的范围内(3.9至15 mU/ml),另一组6例患者的促红细胞生成素高于正常水平(大于15 mU/ml)。两组患者的贫血程度相同,这表明在第二组中骨髓对促红细胞生成素的反应性较低。发现第二组继发性甲状旁腺功能亢进的严重程度更高,这表明甲状旁腺激素在骨髓无反应性中起作用。在正常受试者、尿毒症肾病患者和无肾患者的血浆中,发现生物学活性促红细胞生成素和免疫活性促红细胞生成素之间具有良好的相关性。